Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

139.05
Delayed Data
As of Jun 24
 -4.56 / -3.18%
Today’s Change
122.99
Today|||52-Week Range
157.99
-10.03%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close143.61
Today’s open141.70
Day’s range139.05 - 142.72
Volume260,390
Average volume (3 months)205,758
Market cap$6.1B
Dividend yield--
Data as of 4:02pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+11.67%
Earnings growth (this year)+2.14%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+10.18%
P/E ratio--
Price/Sales6.45
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-1.47-3.36%
MNKMallinckrodt Plc-2.75-4.68%
SGENSeattle Genetics Inc-2.48-6.19%
OPKOPKO Health Inc-0.29-2.97%
Data as of 4:01pm ET, 06/24/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$950.8M
Annual profit (last year)$540.9M
Net profit margin56.92%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Kal Sundaram
Vice President &
Operations Head-Haifa
Itamar karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts

Partner Offers

Search for Jobs